ExploreWatchlistsPricing
  1. JP-listed companies
  2. VITAL KSK HOLDINGS,INC.
  3. Financials
  4. Free cash flow

VITAL KSK HOLDINGS,INC. (3151)

Market cap
¥78.3B
P/E ratio
9.9x
Vital KSK Holdings distributes pharmaceuticals to hospitals, pharmacies and veterinary practices while operating community pharmacies and healthcare services across Japan.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndFree cash flow (Million JPY)YoY (%)
Mar 31, 2025-10,587-148.73%
Mar 31, 202421,725-345.73%
Mar 31, 2023-8,841-317.12%
Mar 31, 20224,072-186.62%
Mar 31, 2021-4,701-50.37%
Mar 31, 2020-9,473-156.99%
Mar 31, 201916,622+85.55%
Mar 31, 20188,958-366.53%
Mar 31, 2017-3,361-23.87%
Mar 31, 2016-4,415-172.91%
Mar 31, 20156,055

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat